Cypralis - Crunchbase Company Profile & Funding

Overview

Cypralis

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Cypralis

CB Rank

2189862

Discovering and developing novel medicines for acute and chronic degenerative diseases

Founded

obfuscation

Private

Cambridge, Cambridgeshire, United Kingdom

51-100

www.cypralis.com/

Biotechnology

Health Care

Details

Operating Status

Active

Company Type

For Profit

Phone Number

+441277367020

Contact Email

contact@cypralis.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

CC-4066

A small molecule drug that has completed Phase I clinical trials for the prevention and treatment of acute kidney injury associated with major surgery.

Cyclophilin Inhibitors

A novel category of small molecule drugs that inhibit cyclophilins, used as tools for validating inhibition of cyclophilins as a therapeutic approach and as starting points for medicinal chemistry programs.